1-167397994-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_002697.4(POU2F1):āc.1130A>Gā(p.Glu377Gly) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000205 in 1,609,822 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002697.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POU2F1 | NM_002697.4 | c.1130A>G | p.Glu377Gly | missense_variant, splice_region_variant | 11/16 | ENST00000367866.7 | NP_002688.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POU2F1 | ENST00000367866.7 | c.1130A>G | p.Glu377Gly | missense_variant, splice_region_variant | 11/16 | 1 | NM_002697.4 | ENSP00000356840 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152228Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 247580Hom.: 0 AF XY: 0.0000224 AC XY: 3AN XY: 133884
GnomAD4 exome AF: 0.0000199 AC: 29AN: 1457594Hom.: 0 Cov.: 31 AF XY: 0.0000207 AC XY: 15AN XY: 725200
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152228Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 22, 2023 | The c.1130A>G (p.E377G) alteration is located in exon 11 (coding exon 11) of the POU2F1 gene. This alteration results from a A to G substitution at nucleotide position 1130, causing the glutamic acid (E) at amino acid position 377 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at